Sign In
Buy MBIO
$0.741
-0.0201 (-2.64%)
At Close: Jun 03, 2026
Ashion Analytics Receives Medicare Coverage for GEM ExTra® Assay for Patients With Advanced Solid Tumors
12:00am, Tuesday, 14'th Jul 2020
Ashion Analytics LLC announced today that Palmetto GBA has awarded Medicare coverage to its proprietary cancer profiling test, GEM ExTra.
Rexgenero Appoints Dr Gilbert Wagener as Senior Vice President and Chief Medical Officer
12:00am, Thursday, 02'nd Jul 2020
Rexgenero, a regenerative medicine company appoints Dr Gilbert Wagener as Senior Vice President and Chief Medical Officer.
How the coronavirus is devastating Southern California’s Pacific Islanders
01:30pm, Monday, 29'th Jun 2020
Infection and death rates are higher in a community that struggles with underlying health conditions and economic disparities.
Hedge Funds Have Never Been This Bullish On Mustang Bio, Inc. (MBIO)
02:15pm, Thursday, 25'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filing
Global CAR T Cell Therapy Market to 2026 - by Regions, Targeted Antigens, Clinical Trials/Study & Companies - ResearchAndMarkets.com
12:00am, Wednesday, 24'th Jun 2020
The
Mustang Bio (NASDAQ:MBIO) Shares Gap Up to $3.40
06:16am, Friday, 19'th Jun 2020
Mustang Bio Inc (NASDAQ:MBIO) gapped up before the market opened on Wednesday . The stock had previously closed at $3.27, but opened at $3.40. Mustang Bio shares last traded at $3.45, with a volume of
Do Options Traders Know Something About Mustang Bio (MBIO) Stock We Don't?
12:39pm, Wednesday, 17'th Jun 2020
Investors need to pay close attention to Mustang Bio (MBIO) stock based on the movements in the options market lately.
-$0.28 EPS Expected for Mustang Bio Inc (NASDAQ:MBIO) This Quarter
07:30am, Monday, 15'th Jun 2020
Wall Street analysts expect Mustang Bio Inc (NASDAQ:MBIO) to announce earnings per share of ($0.28) for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for Mustang Bio�
Mustang Bio Announces Pricing of Public Offering of Common Stock
01:00pm, Thursday, 11'th Jun 2020
Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematolo
Mustang Bio (MBIO) Jumps: Stock Rises 8.2%
12:51pm, Thursday, 11'th Jun 2020
Mustang Bio (MBIO) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Mustang Bio Announces Proposed Public Offering of Common Stock
08:01pm, Wednesday, 10'th Jun 2020
Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematolo
Les valeurs à suivre aujourd'hui à la Bourse de Paris Mercredi 10 juin 2020
07:01am, Wednesday, 10'th Jun 2020Celyad devient Celyad Oncology
12:00am, Wednesday, 10'th Jun 2020
Regulatory News: Celyad SA (Euronext & Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), une société biotechnologique de stade clinique fo
Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy
02:17pm, Thursday, 04'th Jun 2020
CAMBRIDGE, Mass., June 4, 2020 /PRNewswire via COMTEX/ --
CAMBRIDGE, Mass., June 4, 2020 /PRNewswire/ -- Artax Biopharma, Inc., a biotechnology company...
Mustang Bio to Host Virtual Annual Meeting of Stockholders
12:30pm, Thursday, 04'th Jun 2020
Mustang Bio, Inc. (“Mustang”) (MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematolo
